Skip to main content

Plexus to Commercially Manufacture Microsaic's Miniature Mass Spectrometer

NEW YORK (GenomeWeb) – Microsaic Systems and Plexus today announced an agreement for the commercial manufacturing of Microsaic's 4000MiD miniature mass spectrometry system.

The instrument was launched in March 2013 and Plexus was chosen for its expertise with complex sub-assemblies and its ability to provide engineering solutions to support current and future product developments. Microsaic also sought to keep production close to its own facility in Surrey, UK.

Microsaic Chief Executive Colin Jump said in a statement that Plexus is an "excellent strategic fit" for his company, and through the agreement, "we gain the ability to optimize and scale our manufacturing to meet the increasing demand for our product now and in the future."

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.